HC Wainwright & Co. Reiterates Buy on AC Immune, Maintains $16 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Andrew Fein has reiterated a Buy rating on AC Immune (NASDAQ:ACIU) and maintained a price target of $16. This reaffirmation of the company's stock rating and price target suggests continued confidence in AC Immune's prospects.
November 13, 2023 | 3:55 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Andrew Fein has reiterated a Buy rating on AC Immune with a maintained price target of $16, indicating a positive outlook on the stock.
The reiteration of a Buy rating and the maintenance of a $16 price target by a reputable analyst can have a positive impact on investor sentiment and potentially drive the stock price up in the short term. The confidence in the company's prospects by an industry analyst often translates into increased investor interest.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100